Telix Pharmaceuticals Limited American Depositary Shares (TLX)
NASDAQ
11.01
-0.11 (-0.99%)
Closed
Oct 8, 2026
Day's Range
10.9311.10
52 wk Range
6.2813.11
Financial Statements - TLX - Telix Pharmaceuticals Limited American Depositary Shares
Revenue
803.79M▲ 55.6%
Net Income
-7.12M▼ 121.2%Net Margin -0.9%
EBITDA
24.66M▼ 60.7%
Free Cash Flow
-61.06M▼ 1250.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 803.79M | 516.55M | 332.97M | 108.91M | 3.25M | 4.68M |
| Cost of Goods | 377.35M | 180.38M | 123.44M | 44.33M | 1.69M | 2.02M |
| Gross Profit | 426.43M | 336.16M | 209.53M | 64.57M | 1.56M | 2.65M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 18.05M | 55.58M | 34.96M | -50.47M | -65.72M | -49.78M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 11.72M | -407K | -23.95M | -12.06M | 15.66M | 2.95M |
| Pre Tax Income | -5.26M | 37.91M | 2.59M | -47.77M | -53.52M | -47.93M |
| Income Tax | 1.85M | 4.23M | -1.61M | 2.64M | 29.93K | -3.04M |
| Net Income | -7.12M | 33.68M | 4.20M | -50.41M | -53.55M | -44.88M |
| EPS Basic | -0.0211 | 0.1017 | 0.010969 | -0.2279 | -0.285 | -0.1745 |
| EPS Diluted | -0.0211 | 0.0976 | 0.010969 | -0.2279 | -0.285 | -0.1745 |
| Basic Shares Outstanding | 319.18M | 331.22M | 230.01M | 221.20M | 187.72M | 405.36M |
| Diluted Shares Outstanding | 319.18M | 331.22M | 230.01M | 221.20M | 187.72M | 405.36M |
| Ebit | 35.15M | 62.06M | 11.53M | -62.59M | -50.05M | -46.76M |
| Ebitda | 24.66M | 62.77M | 35.50M | -50.46M | -47.74M | -37.94M |
| Net Income Continuous Operations | - | - | - | - | - | - |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
